Prostate-specific membrane antigen positron emission tomography (PSMA-PET) has emerged as a highly sensitive imaging modality for prostate cancer (PCa), outperforming conventional methods like CT, MRI, and bone scintigraphy. Here, FOLH1 is linked to prostate carcinoma.